A randomised, controlled, double-blind, cross-over pilot study assessing the effects of spironolactone, losartan and their combination on heart rate variability and QT dispersion in patients with chronic heart failure

BACKGROUND AND OBJECTIVE: The blocking of aldosterone or angiotensin II receptors improves mortality in patients with chronic heart failure. We explored whether combining losartan and spironolactone would have any added benefit on the known surrogate of mortality by using heart rate variability (HRV...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Shehab, A, Elnour, AA, Struthers, AD
Format: Artigo
Jezik:Inglês
Izdano: Clinics Cardive Publishing 2008
Teme:
Cardiovascular Topics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3971616/
https://ncbi.nlm.nih.gov/pubmed/19104723
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items